FDA Extends Grace Period for Co-Manufacturers to Comply With FSMA Supply-Chain Program Requirements
The Food and Drug Administration will continue its policy of enforcement discretion for food facilities that have co-manufacturing agreements with brand owners and must comply with certain Food Safety Modernization Act requirements for supply-chain programs, it said in a Nov.…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
6 constituent update. The policy was set to end Nov. 6, but FDA has "learned of additional challenges industry is facing in trying to meet the supply-chain requirements," it said. Under the policy, FDA is not taking enforcement action against co-manufacturers that are not in compliance with certain supply-chain program requirements related to supplier approval and supplier verification. Industry has expressed concerns that confidentiality clauses in existing contracts prevent co-manufacturers from obtaining information about suppliers. FDA did not say for how long the policy would be extended, but said it would soon announce the extension in the Federal Register.